Skip to main content
. 2021 Oct 28;54(7):1591–1601. doi: 10.1007/s11255-021-03036-w

Table 4.

Dialysis

Variable No dialysis Dialysis p value
Gender (females in %) 40.8 47.4 0.57
Age (mean years) 77.6 ± 0.7 84.6 ± 1.4 0.002
In-hospital stay (mean days) 16 ± 0.7 19 ± 2.8 0.32
AKIN stage (1/2/3 in %) 73.7/20.7/5.6 21.1/5.3/73.7 < 0.001
Initial eGFR (ml/min) 45.4 ± 1.5 26.6 ± 2.8 < 0.001
Minimal eGFR (ml/min) 26.1 ± 0.8 11.7 ± 1.4 < 0.001
eGFR at demission (ml/min) 41.3 ± 1.6 15.7 ± 2.2 < 0.001
Initial sodium (mMol/L) 137.8 ± 0.3 136.7 ± 1.4 0.46
Sodium at AKI onset (mMol/L) 139 ± 0.37 136.2 ± 1.6 0.087
Initial potassium (mMol/L) 4.4 ± 0.05 4.6 ± 0.17 0.6
Potassium at AKI onset (mMol/L) 4.4 ± 0.05 5 ± 0.18 < 0.001
Initial CRP (mg/L) 34.4 ± 3.9 51.1 ± 18.7 0.52
Peak CRP (mg/L) 96.2 ± 6.5 114.7 ± 21.6 0.28
NT-proBNP (pg/mL) 11,410 ± 966 18,274 ± 3,153 0.016
Vasopressors (%) 20.1 63.2 < 0.001
Ventilation (no/non-invasive/invasive in %) 78.2/12.8/8.9 73.7/15.8/10.5 0.9
ICU treatment (no/1–3/4–10/ > 10 days in %) 74.3/11.2/8.4/6.1 68.4/5.3/21.1/5.3 0.31
Coronary angiography (no/before/after AKI onset in %) 74.9/11.2/14 57.9/31.6/10.5 0.04
Hypertension (%) 89.2 84.2 0.5
Diabetes (no/non-insulin-dependent/insulin-dependent in %) 45.5/14.6/39.9 52.6/10.5/36.8 0.8
Pre-existing CKD (%) 60.7 100 < 0.001
Pre-existing CHF (%) 55.7 63.2 0.53
Pre-existing CAD (%) 50.8 57.9 0.55
Obesity (%) 51.7 52.6 0.93
BMI (mean in mg/qm) 30.6 ± 0.7 27 ± 3.2 0.73
Hyperuricemia (%) 23.2 21.2 0.83
Neoplasia (%) 26.1 21.1 0.63

As opposed to the mortality analyses, 27 variables were analyzed (dialysis excluded). Results are either shown as mean ± SEM or as percentages

Statistically significant p values are in bold (p < 0.05)